0001144204-14-048394.txt : 20140812
0001144204-14-048394.hdr.sgml : 20140812
20140811135749
ACCESSION NUMBER: 0001144204-14-048394
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140630
FILED AS OF DATE: 20140811
DATE AS OF CHANGE: 20140811
EFFECTIVENESS DATE: 20140811
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management I, LLC
CENTRAL INDEX KEY: 0001581219
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15934
FILM NUMBER: 141029954
BUSINESS ADDRESS:
STREET 1: 101 CALIFORNIA STREET, SUITE 4100
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 101 CALIFORNIA STREET, SUITE 4100
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001581219
XXXXXXXX
06-30-2014
06-30-2014
false
Foresite Capital Management I, LLC
101 California Street, Suite 4100
San Francisco
CA
94111
13F HOLDINGS REPORT
028-15934
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
08-11-2014
0
8
119290
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
1894
55767
SH
SOLE
55767
0
0
ACELRX Pharmaceuticals, Inc.
COM
00444T100
8692
847983
SH
SOLE
847983
0
0
Ambit Biosciences Corporation
COM
02318X100
14370
2079569
SH
SOLE
2079569
0
0
BioDelivery Sciences International, Inc.
COM
09060J106
8449
700000
SH
SOLE
700000
0
0
Ignyta, Inc.
COM
451731103
4545
500000
SH
SOLE
500000
0
0
Karyopharm Therapeutics Inc.
COM
48576U106
64118
1377410
SH
SOLE
1377410
0
0
Orexigen Therapeutics, Inc.
COM
686164104
7725
1250000
SH
SOLE
1250000
0
0
Xencor, Inc.
COM
98401F105
9497
817300
SH
SOLE
817300
0
0